About Synavia

Synavia is a consultancy platform dedicated to supporting pharmaceutical development across all stages - from early formulation through clinical trials to marketing authorization submissions. We offer tailored regulatory and development consulting services, helping clients streamline the path from concept to market. With keen interest in updates in the EU regulatory environment, hands-on industrial experience and excellent communication skills, Synavia brings a balanced and integrative approach to drug development. 

Synavia was founded in 2020 by Vít Perlík and Martina Nora Odložilíková, long-time collaborators with complementary expertise spanning both clinical and CMC domains.

In synergistic cooperation with other experienced specialists, Synavia is able to address a broad spectrum of pharmaceutical companies` needs and to seek straightforward and inventive solutions for the development and subsequent registration of your product. We have detailed knowledge of CTD and the contents of dossiers, including the Active Substance Master File and the Certificate of Suitability. We are ready to take up your writing of a large variety of documents, including (but not limited to) clinical and nonclinical overviews, and quality overall summaries. We are able to evaluate potential strategic and regulatory scenarios for your project and help you in the preparation of meetings with Authorities (Scientific Advice). We are ready to help you with efficient planning, designing and monitoring of your clinical studies.